ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Enhanced cytotoxicity to lung cancer cells by mitochondrial delivery of camptothecin

Xie, Jiacui; Wang, He; Huang, Qiudi; Lin, Jiachang; Wen, Huaying; Miao, Yingling; Lv, Le; Ruan, Dongxue; Yu, Xiyong; Qin, Linghao*; Zhou, Yi*广东药学院; 广州医学院; 5; y
European Journal of Pharmaceutical Sciences2023-10-1DOI: 10.1016/j.ejps.2023.106561
1被引10阅读
引用收藏
分享

摘要

Delivering traditional DNA-damaging anticancer drugs into mitochondria to damage mitochondria is a promising chemotherapy strategy. The impermeability of this mitochondrial inner membrane, however, impedes the de-livery of drug molecules that could impact other important biological roles of mitochondria. Herein, the prodrug camptothecin (CPT)-triphenylphosphine (TPP) modified with hyaluronic acid (HA) via electrostatic adsorption (HA/CPT-TPP, HCT) was used to mediate the mitochondrial accumulation of CPT. These nanoparticles (NPs) showed enhanced drug accumulation in cancer cells through tumor targeting. HCT entered acidic lysosomes through endosomal transport, HA was degraded by hyaluronidase (HAase) in acidic lysosomes, and the positively charged CPT-TPP was exposed and accumulated fully in the mitochondria. Subsequently, CPT-TPP significantly disrupted the mitochondrial structure and damaged mitochondrial function, leading to increased reactive oxygen species (ROS) levels and energy depletion. Finally, HCT enhanced lung cancer cell apoptosis via the activation of caspase-3 and caspase-9. Furthermore, greatly increased tumor growth inhibition was observed in nude mice bearing A549 xenograft tumors after the administration of HCT via tail injection. This study demonstrated that the mitochondria-targeted delivery of CPT may be a promising antitumor therapeutic strategy.

学科与关键词

关键词
Mitochondrial deliveryCamptothecinLung cancerTriphenylphosphineApoptosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
European Journal of Pharmaceutical Sciences
发表日期
2023-10-01
卷期
第 189 卷
页码
106561
DOI
10.1016/j.ejps.2023.106561
语言
ENGLISH
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou [201802030002, 202201010783, 2021A1515011367]; Guangdong Natural Science Foundation [2022A030310362, 2022ZDZX2034]; Guangdong Provincial Department of Education Foundation [20221A011107]; Guangzhou Health Science and Technology General Guidance Project; Guangdong Provincial College Students Innovation and Entrepreneurship Training Program Project; Student Innovation Ability Enhancement Program; Second Affiliated Hospital, Guangzhou Medical University; [201604046022]

作者

  • X

    Xie, Jiacui (第一作者)

    guangzhou med univ · 5

  • W

    Wang, He

    2 · guangzhou med univ

查看全部 11 位作者收起作者
  • H

    Huang, Qiudi

    guangzhou med univ

  • L

    Lin, Jiachang

    2 · guangzhou med univ

  • W

    Wen, Huaying

    5 · guangzhou med univ

  • M

    Miao, Yingling

    guangzhou med univ

  • L

    Lv, Le

    guangzhou med univ

  • R

    Ruan, Dongxue

    2 · guangzhou med univ · guangdong pharmaceut univ

  • Y

    Yu, Xiyong

    guangzhou med univ

  • Q

    Qin, Linghao (通讯)

    guangdong pharmaceut univ

  • Z

    Zhou, Yi (通讯)

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417